INMB$1.310.76%-0.01
After Hours: 1.310.00 0.00%
Inmune Bio Inc (INMB)
Date: 2026-11-04 16:00O: 1.35H: 1.40L: 1.28C: 1.33Vol: 258.6k
Inmune Bio Inc stock is traded at $1.31, with a volume of 45,590. It is down -0.76% in the last 24 hours and down -32.12% over the past month. INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Previous Close:
$1.32
Open:
$1.35
24h Volume:
45,590
Relative Volume:
0.22
Market Cap:
$40.56M
Revenue:
$50,000
Net Income/Loss:
-$41.60M
P/E Ratio:
-
EPS:
-$1.69
Net Cash Flow:
-$20.20M
1W Performance:
-14.38%
1M Performance:
-32.12%
6M Performance:
-11.49%
1Y Performance:
-23.84%
1-Day Range:
$1.29$1.40
1-Week Range:
$1.28$1.65
52-Week Range:
$1.09$2.60
Inmune Bio Inc Stock (INMB) Company Profile
Name
Inmune Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 964-3720Address
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
Inmune Bio Inc Stock (INMB) Financials Data
Inmune Bio Inc Stock (INMB) Insider Trading
- Juda ScottJul 02 '26Director
- Transaction
- Option Exercise
- Cost
- $1.40
- #Shares
- 14,801
- Value ($)
- 20,721
- #Shares Total
- 86,404
- Lowdell Mark WilliamJul 02 '26Chief Scientific Officer
- Transaction
- Option Exercise
- Cost
- $1.40
- #Shares
- 7,211
- Value ($)
- 10,095
- #Shares Total
- 1,518,017
- Moss David JJul 02 '26Chief Executive Officer
- Transaction
- Option Exercise
- Cost
- $1.40
- #Shares
- 9,014
- Value ($)
- 12,620
- #Shares Total
- 1,294,883
